Novel RNAi-Mediated Approach to G Protein-Coupled Receptor Deorphanization: Proof of Principle and Characterization of a Planarian 5-HT Receptor by Zamanian, Mostafa et al.
Biomedical Sciences Publications Biomedical Sciences
7-18-2012
Novel RNAi-Mediated Approach to G Protein-
Coupled Receptor Deorphanization: Proof of
Principle and Characterization of a Planarian 5-HT
Receptor
Mostafa Zamanian
Iowa State University, mostafaz@iastate.edu
Prince N. Agbedanu
Iowa State University, agbedanu@iastate.edu
Nicholas J. Wheeler
Iowa State University, wheelern@iastate.edu
Paul McVeigh
Queen's University Belfast
Michael J. Kimber
Iowa State University, michaelk@iastate.edu
See next page for additional authors
Follow this and additional works at: http://lib.dr.iastate.edu/bms_pubs
Part of the Neuroscience and Neurobiology Commons, and the Parasitic Diseases Commons
The complete bibliographic information for this item can be found at http://lib.dr.iastate.edu/
bms_pubs/16. For information on how to cite this item, please visit http://lib.dr.iastate.edu/
howtocite.html.
This Article is brought to you for free and open access by the Biomedical Sciences at Iowa State University Digital Repository. It has been accepted for
inclusion in Biomedical Sciences Publications by an authorized administrator of Iowa State University Digital Repository. For more information, please
contact digirep@iastate.edu.
Novel RNAi-Mediated Approach to G Protein-Coupled Receptor
Deorphanization: Proof of Principle and Characterization of a Planarian
5-HT Receptor
Abstract
G protein-coupled receptors (GPCRs) represent the largest known superfamily of membrane proteins
extending throughout the Metazoa. There exists ample motivation to elucidate the functional properties of
GPCRs given their role in signal transduction and their prominence as drug targets. In many target organisms,
these efforts are hampered by the unreliable nature of heterologous receptor expression platforms. We validate
and describe an alternative loss-of-function approach for ascertaining the ligand and G protein coupling
properties of GPCRs in their native cell membrane environment. Our efforts are focused on the phylum
Platyhelminthes, given the heavy health burden exacted by pathogenic flatworms, as well as the role of free-
living flatworms as model organisms for the study of developmental biology. RNA interference (RNAi) was
used in conjunction with a biochemical endpoint assay to monitor cAMP modulation in response to the
translational suppression of individual receptors. As proof of principle, this approach was used to confirm the
neuropeptide GYIRFamide as the cognate ligand for the planarian neuropeptide receptor GtNPR-1, while
revealing its endogenous coupling to Gαi/o. The method was then extended to deorphanize a novel Gαs-
coupled planarian serotonin receptor, DtSER-1. A bioinformatics protocol guided the selection of receptor
candidates mediating 5-HT-evoked responses. These results provide functional data on a neurotransmitter
central to flatworm biology, while establishing the great potential of an RNAi-based deorphanization protocol.
Future work can help optimize and adapt this protocol for higher-throughput platforms as well as other phyla.
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Introduction
G protein-coupled receptors (GPCRs) have been the subject of
intense research scrutiny due to their central role in eukaryotic
signal transduction and their exploitability as drug targets [1–3].
Once identified, GPCRs typically undergo deorphanization, the
process of pairing orphan receptors with their cognate ligands.
Current approaches to GPCR deorphanization have severe
limitations and are inefficient for large-scale projects. The
predominant approaches all require the transient or stable
heterologous expression of GPCRs in a surrogate cell system
and in most cases, this expression occurs in cells derived from
other species and phyla [4–6]. This has introduced a significant
bottleneck in the way of both the pharmacological and structural
characterization of GPCRs [4,7].
The complex regulatory processes that guide the correct folding
and export of receptors to the cell membrane [8–11] are not
necessarily highly-conserved across cell lineages. In the event that
a GPCR is successfully expressed on the surface of a host cell, the
receptor must operate in conjunction with a foreign complement
of accessory and signaling proteins. Further, the structural and
functional integrity of receptors can be altered by local membrane
composition [12,13]. The exact post-translational requirements for
proper receptor expression and function can vary greatly among
receptors, making the task of identifying a suitable heterologous
system unique to each receptor and, ultimately, dependent on trial
and error [4].
Although heterologous expression is not a theoretically
challenging feat, individual targets routinely prove to be recalci-
trant and consume inordinate effort. In view of these concerns, a
simple receptor deorphanization method that could be applied in a
native cell or membrane environment could side-step some of
these limitations.
Flatworm GPCRs
The phylum Platyhelminthes houses prominent human
pathogens as well as tractable model organisms. Flatworm
GPCRs represent lucrative anthelmintic targets, as evidenced by
the biological activities of their putative ligands [14,15] and the
crucial biological functions of these receptors in other organisms
[16,17]. Signaling pathways associated with the GPCR super-
family have been identified as potential targets for life-cycle
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interruption of flatworm parasites [18,19]. The recent availabil-
ity of platyhelminth genomic data [20–22] has led to the
accumulation of a wealth of receptor and ligand data. A
comprehensive in silico protocol revealed over 117 Schistosoma
mansoni and 460 Schmidtea mediterranea GPCRs, which were
classified using phylogenetic, homology-based, and machine-
learning approaches [23]. Bioinformatics and proteomics-based
studies have similarly led to the expansion of the known set of
putative GPCR ligands [24,25].
The pharmacological characterization of orphan flatworm
receptors is likely to generate valuable drug discovery leads, while
enhancing our understanding of basic receptor biology in this
important phylum. Reliance on heterologous expression platforms
have hampered efforts to implement functional assays to identify
receptor agonists. Only a handful of flatworm GPCRs have thus
far been deorphanized, with receptors expressed in such divergent
cellular environments as CHO [26], HEK293 [27,28], COS7
[27], yeast [28,29], and Xenopus oocyte cells [30]. We describe a
relatively simple loss-of-function deorphanization approach that
could be applied in a native cell or membrane environment. This
alternative strategy could help catalyze a first-pass mapping of
receptors and ligands in this and other phyla.
Inversing the Paradigm: RNAi as a Deorphanization Tool
We validate an RNA interference (RNAi)-based method that
allows receptors to undergo deorphanization without the need for
full-length cloning and transport to a heterologous expression
system. In principle, a collection of putative ligands are screened
against membrane preparations to evaluate their effects on second-
messengers downstream of GPCR activation. RNAi is then used to
assay whether observed responses can be altered or abolished by
the knockdown of individual receptors from the membrane
preparations. A successful ‘‘hit’’ confirms expression of a given
receptor, functionally pairs the receptor with a given ligand, and
couples the receptor with a specific G protein signaling pathway.
Bioinformatics approaches can be used to help identify receptors
as putative targets for a particular ligand, or conversely, to narrow
the list of potential ligands for a given receptor.
The primary biochemical endpoints of GPCR activation are
typically assayed by recording agonist-evoked changes in cAMP
(Gas and Gai=o) or Ca
2z (Gaq) levels. A variety of established
labeling and detection schemes (e.g. fluorescent, luminescent, and
radioisotope) are available for these second messengers [31]. In
this study, we focus our efforts on the Gas and Gai=o pathways and
employ a radioimmunoassay (RIA) for cAMP detection. Moni-
toring adenylyl cyclase modulation of cAMP allows us to examine
two of the three major GPCR activation endpoints.
While this loss-of-function approach limits pharmacological
analysis, it is likely adaptable to higher-throughput platforms and
can serve as an efficient ligand-receptor mapping tool for certain
receptor classes. It should be noted that ligands and receptors can
display pharmacological promiscuity; ligands can act through
more than one receptor and receptors can respond to more than
one ligand, with a range of affinities. Further, receptors responsive
to a given ligand do not necessarily share the same G protein
coupling profile and are likely to be expressed in different
abundances. However, this approach only concerns itself with the
contribution of individual receptors to differences between control
and RNAi response profiles. The scale and directionality of these
differences provide information relevant to ligand responsivity and
G protein coupling, respectively. The basic logic of this
deorphanization strategy is outlined in Figure 1.
Results and Discussion
cAMP Assay Optimization and Ligand Screen
A cell membrane preparation protocol was adapted [32] and
optimized for planaria, and used to generate samples for treatment
with putative GPCR ligands. The downstream effects of ligand
incubation on cAMP levels were monitored using a cAMP RIA. A
screen was first carried out on Dugesia (Girardia) tigrina membrane
preparations with a small number of peptides and biogenic
amines. These ligand classes are prominent in platyhelminth
biology [14,15,24,25], and there is a strong likelihood that a subset
signals through one or more receptors coupled to either the Gas or
Gai=o pathways. This would presumably be made apparent by
stimulation of basal cAMP levels or inhibition of forskolin (Fk)-
stimulated cAMP levels [33] as measured by RIA, respectively.
Included in this initial screen were the only two ligands
definitively coupled to planarian GPCRs: the neuropeptide
GYIRFamide and the biogenic amine serotonin (5-HT; 5-
hydroxytryptamine). It was a reasonable assumption that both
GYIRFamide and 5-HT would modulate cAMP levels in a whole
organism membrane preparation. The D. tigrina receptor GtNPR-
1 was previously deorphanized, showing a potent dose-dependent
response to the neuropeptide GYIRFamide in mammalian cell
culture [26]. Chimeric G proteins (Gaqi5 and Gaqo5) were used to
divert downstream GtNPR-1 signaling through the Gaq pathway,
suggesting this receptor is Gai=o-coupled in its native environment.
More recently, a Dugesia japonica 5-HT GPCR has been
deorphanized using Xenopus laevis oocytes [30], and there is long-
established evidence of 5-HT stimulation of cAMP in both S.
mansoni [34,35] and other planarian species [36], suggesting that 5-
HT acts through one or more Gas-coupled GPCRs.
Alongside GYIRFamide and 5-HT, we included neuropeptide F
(NPF) and octopamine as putative ligands. NPF has been shown to
inhibit Fk-stimulated cAMP production in membranes isolated from
S. mansoni [32]. Given the identification of planarian NPF homologues
[24,25], we hypothesized that this peptide would have a similar
inhibitory effect on cAMP levels. The results of this primary screen
show that 10{5 M 5-HT drastically stimulates cAMP production,
with Fk and 5-HT together leading to greater cAMP production than
either Fk or 5-HT alone (Figure 2a). No other putative ligand
significantly increased cAMP compared to basal levels. Further, 10{4
M GYIRFamide, 10{4 M NPF, and 10{4 M octopamine inhibit Fk-
stimulated cAMP accumulation in Dugesia membrane preparations
(Figure 2b) to varying degrees. Inhibition was greatest for NPF at
,82%, followed by GYIRFamide at ,24%. These changes in
[cAMP] can be viewed as the ‘additive response profile’ for each
ligand. By this we refer only to the total measured effect of the ligand
on the second messenger, as potentially mediated by one or more
receptors. This is to acknowledge that different receptors that respond
to the same ligand may contribute in different ways to the overall
response being measured.
We chose to first pursue the response profiles of GYIRFamide,
provided that GtNPR-1 is a known target of GYIRFamide in D.
tigrina. As proof of principle, we investigated whether or not this
would be apparent using this loss-of-function assay. Given that the
inhibition of adenylate cyclase by GYIRFamide is less potent than
that brought on by NPF, this also serves as a more difficult trial for
validation of assay sensitivity.
Coupling cAMP Assay with RNAi: GtNPR-1 Proof of
Principle
Establishing RNAi-mediated receptor suppression.
Double-stranded (ds) RNA was introduced to isolated D. tigrina
RNAi-Based Receptor Deorphanization
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colonies using a bacterial-mediated feeding protocol. Planaria
were randomly selected, isolated into treatment groups, and fed
either non-flatworm control dsRNA or GtNPR-1 dsRNA. A two-
week RNAi feeding cycle consisted of four evenly-spaced feedings,
followed by a four-day starvation period. Semi-quantitative RT-
PCR was used to confirm mRNA knockdown. A small number of
planarians were randomly selected from both experimental and
control groups to assay GtNPR-1 suppression, and the remaining
planarians were used for membrane assays. Significant GtNPR-1
knockdown (w 80%) is consistent and apparent in the exper-
imental group, while GtNPR-1 expression remains robust in the
control group (Figure 3) relative to endogenous standard.
Deorphanization via comparison of response
profiles. Membranes were prepared from both control and
GtNPR-1 dsRNA-fed planarians, and treated with Fk (10{4 M),
GYIRFamide (10{4 M), and Fk (10{4 M)zGYIRFamide
(10{4 M). RIA was used to assay cAMP levels corresponding to
these treatments. Comparison of the response profiles reveals near-
complete abolishment of GYIRFamide-evoked inhibition of Fk-
stimulated cAMP in the GtNPR-1 knockdown group (Figure 4,
Table 1). Overall, GYIRFamide reduces Fk-stimulated cAMP
production by an average of ,30% in the control group, and this
inhibition was completely abolished by the suppression of GtNPR-1
expression in the RNAi group. These results confirm that GtNPR-
1 is agonized by GYIRFamide and further establish that this
receptor is natively coupled to the Gai=o signaling pathway.
In silico Target Selection
The two ligands that most drastically stimulated and inhibited
adenlyate cyclase activity in our primary ligand screen were 5-HT
and NPF, respectively. We decided to focus on 5-HT in an
attempt to deorphanize a Gas-coupled receptor. To identify and
rank 5-HT receptor candidates, a profile HMM was built with
sequences procured from GPCRDB [37]. Training was focused on
62 full-length invertebrate 5-HT and 5-HT-like receptors. This
model was used to search against S. mediterranea GPCR sequence
datasets [23] and the results were ranked by E-value. The top 20
receptor candidates were used as BLASTp [38] queries against the
NBCI ‘‘nr’’ database. This was used to identify receptors
displaying 5-HT receptor homology, and to filter against receptors
that displayed a non-specific range of biogenic amine receptor-
related homology.
Receptors that survived this filter were compared to their
nearest-related S. mansoni and D. japonica homologs (Table 2).
While the bioinformatics evidence suggests multiple receptor
targets for 5-HT, we narrowed our list to the best-conserved
receptors between parasitic and free-living flatworms and used
degenerate PCR to amplify a putative 5-HT receptor from D.
tigrina. The selection strategy is outlined in Table 2. The amplified
receptor is labeled DtSER-1 and maximum parsimony phyloge-
netic analysis places this receptor among a group of putative free-
living and parasitic flatworm 5-HT receptors that are significantly
diverged from those found in other phyla (Figure 5, Figure 6).
RNAi-based Deorphanization of Planarian 5-HT Receptor
DtSER-1 transcript expression was confirmed via PCR, and
knockdown was elicited following the protocol described for
GtNPR-1. Similar levels of transcript knockdown were obtained
(Figure 7). Membranes from control and DtSER-1 dsRNA-fed
worms were isolated and treated with 5-HT (10{4 M). The
response profiles reveal a significant decrease (w30%) in 5-HT
evoked cAMP stimulation in the DtSER-1 RNAi preparations
compared to the control preparations. As with the neuropeptide
receptor knockdown experiments, basal cAMP levels did not differ
between control and experimental groups (Figure 8, Table 3).
These results signify the successful deorphanization of DtSER-1 in
its native membrane environment. DtSER-1 responds to 5-HT
and is coupled to the Gas pathway. Serotonin receptors are
implicated in motility and regeneration due to the phenotypic
effects of serotonin in this phylum [39,40]. Given that this receptor
mediates significant increases in cAMP levels in response to
serotonin, it is likely involved in these or other important
physiological processes.
Figure 1. Logic of RNAi-based deorphanization experiment. The general set of experimental outcomes for an RNAi-based deorphanization
experiment focused on the Gas and Gai pathway are shown. Letters A{D and A’{D’ each represent cAMP datasets for particular treatment
conditions. Potential results are described with respect to the notion that a given ligand may act on multiple GPCRs that are not necessarily coupled
to the same G protein (Gas or Gai). Abbreviations: NT, no treatment; Fk, forskolin; L, ligand; R, receptor; RNAi-control, control membrane preparation;
RNAi-R, R-suppressed membrane preparation; x, cAMP measurement variable. Asterisks (*) are used to denote normalized data.
doi:10.1371/journal.pone.0040787.g001
RNAi-Based Receptor Deorphanization
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Conclusions
This study establishes the utility of combining RNAi with
biochemical endpoint assays as a means of deorphanizing GPCRs
in their native membrane environment. The approach was first
validated using the only deorphanized flatworm neuropeptide
GPCR (GtNPR-1), confirming agonism by GYIRFamide while
providing information about its endogenous G protein coupling
profile. The orphan D. tigrina GPCR DtSER-1 was shown to
respond to 5-HT, revealing its endogenous G protein pathway and
illustrating the utility of applying an in silico strategy to candidate
receptor selection. While this loss-of-function strategy side-steps
some of the concerns and difficulties associated with heterologous
GPCR expression, there is significant room for improving both the
sensitivity and scalability of this assay.
The heavy tissue requirements of the membrane preparation
protocols employed introduce a potential rate-limiting step.
Further optimizations of membrane or whole cell preparation
protocols in this phylum could allow for more efficient and robust
pharmacological analysis. This assay could conceivably be adapted
to higher-throughput platforms, extended to include GPCRs that
signal through the Gaq pathway, and employed in other phyla that
are amenable to RNA interference-mediated gene knockdown.
Conveniently, establishing receptor-specific RNAi in planaria
allows for the accumulation of loss-of-function phenotypic data in
Figure 2. Peptide and biogenic amine ligand cAMP screen performed against isolated D. tigrina membranes. RIA cAMP outputs are
normalized and shown as mean + SEM, with asterisks representing statistically significant differences compared to a control bar (#); *Pv0.05,
**Pv0.01, ***Pv0.001, one-way ANOVA, Tukey post hoc test. Top: red-outlined bars signify ligands that stimulate cAMP compared to basal levels,
likely mediated by Gas-coupled GPCRs. Bottom: red-outlined bars signify ligand inhibition of Fk-stimulated cAMP, likely mediated by Gai=o-coupled
GPCRs. Serotonin (5-HT) stimulates basal cAMP, while octopamine (Oct), GYRIFamide (GYIRF), and neuropeptide F (NPF) all inhibit Fk-stimulated cAMP
at 100 uM. These changes in cAMP are presumably receptor-mediated, and should therefore be altered in a ligand-specific manner by subtraction of
particular receptor targets from cell membranes via RNAi.
doi:10.1371/journal.pone.0040787.g002
RNAi-Based Receptor Deorphanization
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parallel to pharmacological data. In this regard, the study of
planarians can inform flatworm parasite biology. Biasing the
receptor and ligand pool to those best conserved between parasitic
and free-living flatworms could shed light on new targets for
chemotherapeutic intervention.
Materials and Methods
Planarian Maintenance
Dugesia tigrina (Ward’s Natural Science, Rochester, NY) colonies
were maintained in the laboratory in aerated spring water on a
regular feeding cycle (,2–3 times per week). Planaria were
randomly selected and isolated in ,50-worm groupings for RNAi
feeding cycles and cAMP assays.
RNA Interference
Primer3 [41] was used to select primers to selectively amplify
400–600 bp fragments of GtNPR-1 and 5HT receptor candidate
DtSER-1. BLAT [42] was used to help guard against potential off-
target effects of silencing triggers using the very nearly-related S.
mediterranea genome. A 465 bp fragment of GtNPR-1 was amplified
from a full length clone of Gt-NPR1 housed in pcDNA3.1(+), with
the primers 59-TGGATCTTTCCAGCGACTCT-39 (forward)
and 59-ATGGTTCGTTCGACGTTTTC-39 (reverse). A 586 bp
fragment of DtSER-1 was amplified from D. tigrina cDNA isolated
using RNAqueous (Ambion) and RETRoscript (Ambion), with a
degenerate forward primer: 59-GGKATGGAAGTATTTCTGG-
Figure 3. Semi-quantitative PCR reveals GtNPR-1 knockdown. Lane 1 is a 100 bp DNA ladder, lanes 2–5 represent individual GtNPR-1 dsRNA-
fed planarians, and lanes 6–9 represent control dsRNA-fed planarians. The bottom band (,300 bp) is the 18S internal standard, and the top band
(,400 bp) shows GtNPR-1 expression. The top band disappears in the experimental group, confirming near abolishment of receptor expression in
these worms. Relative band intensities (GtNPR-1/18S rRNA) for GtNPR-1 RNAi group: 0.44+0.15. Relative band intensities for control group (band
location manually selected): 0.08+0.02. This corresponds to w80% knockdown of GtNPR-1 transcript.
doi:10.1371/journal.pone.0040787.g003
Figure 4. RNAi-based GtNPR-1 deorphanization. Treatment
groups are Control (control dsRNA) and GtNPR-1 RNAi (GtNPR-1 dsRNA).
Treatments are C (control), Fk (10{4 M forskolin), and Fk z GYIRF
(10{4 M forskolin and 10{4 M GYIRFamide). Each bar is the mean (+
SEM) of 3 individual experiments. Basal cAMP levels were set as a
baseline for each individual experiment, and cAMP values were
normalized with respect to the level of Fk-stimulated cAMP (set at
100%). This allowed us to join datasets with differing basal cAMP levels,
due to variance in the quality and yield of individual membrane
preparations. Analysis of the raw cAMP values of individual experiments
renders the same results (Table 1). Asterisks indicate significance at
Pv0.001 (***), and ‘‘ns’’ indicates no significant difference (one-way
ANOVA, Tukey post hoc test).
doi:10.1371/journal.pone.0040787.g004
Table 1. RNAi-based GtNPR deorphanization cAMP raw
values.
EXP Treatment Control GtNPR1 RNAi
C 62.0562.46 60.8361.91
1 Fk 102.4564.06 101.4761.59
Fk + G 85.0261.59*** 103.0364.27ns
C 27.8860.97 33.5461.27
2 Fk 57.3762.68 58.7861.64
Fk + G 48.6761.23** 57.8960.93ns
C 81.4964.06 55.1661.60
3 Fk 215.96610.99 129.7963.61
Fk + G 195.6366.17** 132.6064.62ns
RIA-determined cAMP values (pM) are provided for three separate experiments
(mean + SEM). Treatments: C (control), Fk (Forskolin), Fk + G (Forskolin +
GYIRFamide). The amount of isolated membrane differs between experiments,
as evidenced by basal cAMP levels. This is in part due to differences in the size,
number, and feeding behavior of worm batches used for membrane isolation.
Analysis (one-way ANOVA, Tukey) of these raw datasets establishes
abolishment of cAMP inhibition brought on by GYIRFamide associated with
GtNPR-1 suppression. For each experimental grouping, Fk is compared to Fk +
G. Asterisks indicate significance at Pv0.001 (***), Pv0.01 (**), and ‘‘ns’’ means
no significant difference.
doi:10.1371/journal.pone.0040787.t001
RNAi-Based Receptor Deorphanization
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GRAT-39 (forward) and 59-TGGCATCTTCTTG GGCCA-
TATTTCT-39 (reverse). An RNAi control sequence was amplified
from Aedis aegypti cDNA with primers 59-AATGCCGGCCTG-
TTTCCTAT-39 (forward) and 59-AGCATCCTTTTTCTTGT-
GCG-39 (reverse), corresponding to a putative odorant receptor
(VectorBase id: AAEL013422 [43]). Second-round PCR was
performed for each target sequence using the original gene-specific
primers flanked by Gateway Cloning system (Invitrogen) recom-
bination sites: 59-GGGG- attB1-39 (forward) and 59-GGGG- attB2-
39 (reverse). Entry sequences were subcloned into the pPR244
(pDONRdT7) [44] destination vector with corresponding attP1
and attP2 recombination sites using BP Clonase II (Invitrogen).
Clones were transformed into TOP10 Electrocompetent E. coli
(Invitrogen) and sequence confirmed. RNAi vectors were intro-
duced to HT115(DE3) cells for transcription of dsRNA, followed
by bacterial-mediated feeding per standard protocol [45].
Semi-quantitative RT-PCR
Total RNA was extracted from individual D. tigrina with
RNAqueous (Ambion), followed by removal of DNA contaminants
with TURBO DNase (Ambion). First strand cDNA synthesis was
carried out with the RETROscript kit (Ambion), as part of a two-
stage RT-PCR. PCR optimization was carried out with the
QuantumRNA 18S Internal Standards kit (Ambion) per manu-
facturer instructions. 18S ribosomal RNA was used as an
endogenous standard for normalizing measures of gene expression
and reducing sample-to-sample variation. cDNA samples were
used in parallel as templates for multiplex PCR with gene-specific
and 18S rRNA primer pairs. PCR reaction products were
visualized on 1.2% electrophoretic gel with the Kodak Gel Logic
112 imaging system, and amplicon intensities were analyzed with
standard software to derive relative transcript abundances.
Table 2. 5-HT receptor candidate selection.
S. mediterranea HMM BLAST TM S. mansoni D. japonica
mk4.013690.00.01 2.90E2108 + 6 Smp160020 D 8E-45 (157)
mk4.005939.01.01 3.90E285 + 6 Smp148210 | 8E-64 (195) DjSER-7 | 3E-73 (364)
mk4.011371.00.01 1.20E271 2 7
mk4.001585.00.01 3.00E270 + 5 Smp126730 | 9E-65 (258) 5HTLpla4 | 1E-141 (310)
mk4.007388.02.01 9.60E269 + 5 5HTLpla1 D 1E-127 (298)
mk4.029325.00.01 2.30E265 2 7
mk4.000656.10.01 1.10E261 2 7
mk4.004462.02.01 5.10E251 + 5 DjSER-7 D 1E-115 (227)
mk4.011006.00.01 3.30E250 + 5
mk4.003202.01.01 1.10E249 2 7
mk4.000943.09.01 1.80E248 + 5 Smp149770 D 2E-31 (113)
mk4.000354.16.01 1.70E247 2 7
mk4.012659.00.01 5.60E246 2 7
mk4.011160.01.01 2.90E245 2 7
mk4.000742.09.01 5.00E244 2 7
mk4.001678.03.01 1.20E240 2 7
mk4.010158.01.01 1.60E238 + 5
mk4.013827.00.01 7.80E235 + 5 Smp126730 D 1E-59 (176)
mk4.001587.06.01 1.60E229 + 5 Smp148210 | 8E-63 (179) 5HTLpla1 | 2E-63 (234)
mk4.000526.00.01 3.60E228 + 6
mk4.017426.00.01 – 2 5
mk4.017583.00.01 – + 5
mk4.012214.00.01 – + 3
mk4.011860.00.01 – + 3
mk4.012270.00.01 – + 3
mk4.013819.05.01 – + 3 Smp149770 D 2E-34 (135)
mk4.010946.00.01 – + 5
5-HT profile HMM hits are ranked by E-value for S. mediterranea. Additional sequences were appended via homology searches. This putative list of planarian 5-HT
receptors was searched against the NCBI nr database using BLASTp. Receptors that exclusively showed serotonin-related homology in their top returned hits are
marked with ‘+’. HMMTOP [50] was used to predict the number of TM domains for each sequence. Putative 5-HT receptors from S. mansoni [23] and D. japonica [51]
were searched against the filtered HMM pool. The two nearest-related homologs for each of four S. mansoni receptors are shown, along with E-value and overlap length
for each pairing. Similarly, the top pairings for each of three D. japonica receptors are shown. Three sequence clusters (bold) show high sequence conservation between
parasite and planarian sequences. DjSER-7 has been previously deorphanized [30] and we therefore excluded this cluster from further consideration. Among the two
remaining options, our choice of the highlighted sequence cluster is justified as follows: 1) the planarian sequences in this grouping share the highest level of sequence
identity with their parasite sequelog, 2) the presence of two closely-related planarian sequences improves the likelihood of success for degenerate PCR as a strategy to
amplify the D. tigrina homolog, and 3) deorphanization of a receptor in this cluster will assign a pharmacological identity to a novel subset of GPCRs.
doi:10.1371/journal.pone.0040787.t002
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Membrane Preparation
Planaria were washed twice with cold cAMP buffer contain-
ing 50 mM sucrose, 50 mM glycylglycine, 10 mM creatine
phosphate, 2 mM MgCl2, 0.5 mM isobutylmethylxanthine
(IBMX), 1 mM dithiothreitol (DTT), 0.02 mM EGTA, 10
units/ml creatine kinase, and 0.01% bovine serum albumin.
Worms were kept on ice for 5 min and then homogenized on
ice for 2 min with a Teflon homogenizer. This preparation was
centrifuged at 5,0006g for 5 min, with the pellet that included
cell debris discarded. This centrifugation step was then repeated.
The supernatant was centrifuged at 40,0006g for 30 min at
4uC. The supernatant was discarded, and the membrane-
containing pellet was resuspended via sonication in cAMP
buffer suplemented with 0.1 mM ATP and 0.1 mM GTP. Total
suspension volume was set at 500 mL/sample, such that each
sample would contain cell membranes from ,3 worms. 500 mL
aliquots of this membrane preparation correspond to individual
reactions in the cAMP assay.
Samples were incubated with various concentrations (and
combinations) of forskolin and/or putative ligands (peptide or
biogenic amine) at 37uC for 20 min to stimulate cAMP
production. Forskolin and peptide ligands were dissolved in
DMSO, with final reaction mixtures containing v0.1% DMSO.
DMSO has no measurable effect on cAMP in this range (data not
shown). Samples were centrifuged at 3,0006g for 5 minutes after
ligand incubation, and 400 mL of supernatant from each sample (3
samples per treatment) was transferred into a fresh tube for cAMP
determination using radioimmunoassay.
cAMP Determination
cAMP levels were measured with RIA as previously described
[46] with minor modifications. 100 mL aliquots from each sample
or known standard (standard curve range: 4 – 512 fmol cAMP)
Figure 5. Maximum parsimony tree of serotonin receptors. Phylogenetic analysis was performed using planarian (S. mediterranea and D.
japonica), parasite (S. mansoni), human and C. elegans 5-HT receptors and putative 5-HT receptors. TM domains I-VII were were extracted from the
alignment for bootstrapping (bootstrap value ~ 1000). Outlined receptors are significantly diverged from vertebrate and ecdysozoan serotonin
receptors. DtSER-1 (red) was amplified using a degenerate PCR strategy and was chosen to undergo RNAi-based deorphanization.
doi:10.1371/journal.pone.0040787.g005
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were acetylated and incubated overnight at 4uC with primary
cAMP antibody (1:30,000) and cAMP[125I] (,20,000 cpm). 100
mL of NRP (1:80,000) and secondary antibody (goat anti-rabbit
IgG; 1:40,000) were added, followed by incubation at 25uC for
10 min. 100 mL of 50% normal bovine plasma and 1 mL of ice-
cold PEG were added to the scintillation vials. Samples were
Figure 6. Multiple sequence alignment of serotonin receptors. DtSER-1 is shown aligned with other putative flatworm 5-HT receptor
sequences that fall into to the same phylogenetic grouping (highlighted in Figure 5). This analysis encompasses low-entropy TM domains I–V, and TM
domains are demarcated above the alignment in blue as predicted by HMMTOP [50]. Consensus (absolutely conserved) residues are shown for the
flatworm receptors, and those conserved between this flatworm receptor grouping and a human serotonin receptor (5-HT5A) are highlighted in blue.
doi:10.1371/journal.pone.0040787.g006
Figure 7. Semi-quantitative PCR reveals DtSER-1 knockdown. Lane 1 is a 100 bp DNA ladder, lanes 2–5 represent individual DtSER-1 dsRNA-fed
planarians, and lanes 6–9 represent control dsRNA-fed planarians. The bottom band (,300 bp) is the 18S internal standard, and the top band
(,480 bp) shows DtSER-1 expression. The top band disappears in the experimental group, confirming near abolishment of DtSER-1 receptor
expression in these worms.
doi:10.1371/journal.pone.0040787.g007
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centrifuged at 3,000 rpm (4uC) for 20 min. The supernatants were
aspirated and 125I levels in the pellets were assayed via gamma
counter (Packard, B5002). For a given experiment, each sample
was assayed in triplicate.
Bioinformatics
HMMER-2.3.2 [47] was used to build a profile HMM for
invertebrate 5-HT receptors. Training sequences were procured
from GPCRDB and aligned with Muscle 3.6 [48]. The profile
HMM was constructed with hmmbuild and calibrated with
hmmcalibrate. This model was used to search a curated dataset of
putative S. mediterranea receptors with hmmpfam. The resulting
matches were ranked by E-value and the top 20 full-length hits
were further examined. Putative hits were matched with their
nearest-related S. mansoni and D. japonica homologs, and also
searched against the NCBI nr database with BLASTp. Maximum
parsimony phylogenetic analysis was carried out with the Phylip
3.6 [49] package.
Statistical Analysis
In cases where a ligand had an overall inhibitory effect on Fk-
stimulated cAMP, basal cAMP levels were set as a baseline for
individual RIA experiments and cAMP values were normalized
with respect to the level of Fk-stimulated cAMP (set at 100%). In
cases where a ligand had an overall stimulatory effect on cAMP,
cAMP values were normalized with respect to basal cAMP (set at
100%). This allowed us to join datasets from repeated experiments
with differing basal cAMP levels due to variance in the quality and
yield of individual membrane preparations. One-way analysis of
variance (ANOVA) was used with Tukey’s post hoc test for multiple
comparison analysis of cAMP levels associated with different
treatments, for both normalized and raw values. Significances are
reported at Pv0.05, Pv0.01, and Pv0.001.
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